Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Breast Cancer Metastatic × nirogacestat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Breast Cancer Metastatic 1

Interventions

Fulvestrant 2 tusamitamab ravtansine 1 palbociclib 1 nirogacestat 1 exemestane 1 Tamoxifen 1 Letrozole 1 Gemcitabine 1 Docetaxel 1 Capecitabine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01876251 2019-03-15

A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer

Pfizer

Phase 1 Terminated

30 enrolled 29 charts

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡